Compounds for immunotherapy of prostate cancer and methods for their use

作者: Davin C. Dillon , Jiangchun Xu

DOI:

关键词: Cancer researchImmunotherapyDNAImmunologyProstateProstate cancerMedicine

摘要: Compounds and methods for treating prostate cancer are provided. The inventive compounds include polypeptides containing at least a portion of tumor protein. Vaccines pharmaceutical compositions immunotherapy comprising such polypeptides, or DNA molecules encoding also provided, together with preparing the polypeptides.

参考文章(108)
L. Fu, M. D. Minden, S. Benchimol, Translational regulation of human p53 gene expression. The EMBO Journal. ,vol. 15, pp. 4392- 4401 ,(1996) , 10.1002/J.1460-2075.1996.TB00812.X
S Welt, G Ritter, Antibodies in the therapy of colon cancer. Seminars in Oncology. ,vol. 26, pp. 683- 690 ,(1999)
Kenneth L Melmon, Julia L Greenstein, Parisa Khosropour, Histamine derivatives and methods for their use as immunomodulators ,(1993)
Surya K. Goli, Olga Bandman, Prostate-specific kallikrein ,(1997)
George A. Komatsoulis, Laurie A. Brewer, Gregory A. Endress, David W. Lafleur, Kimberly A. Florence, Charles Florence, Roxanne Duan, Steven M. Ruben, Ping Feng, Henrik S. Olsen, Reinhard Ebner, Paul A. Moore, Yanggu Shi, Paul E. Young, Craig A. Rosen, Daniel R. Soppet, 70 human secreted proteins ,(1998)
James P. Merryweather, Lawrence S. Cousens, Patricia A. Tekamp-Olson, Jeffrey R. Shuster, Expression using fused genes providing for protein product ,(1986)